Unique ID issued by UMIN | UMIN000027275 |
---|---|
Receipt number | R000029304 |
Scientific Title | Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms |
Date of disclosure of the study information | 2017/05/09 |
Last modified on | 2024/04/01 15:54:24 |
Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms
Laparoscopic observation of abdominal aortic aneurysms
Laparoscopic intraperitoneal observational study in patients undergoing open surgery for abdominal aortic and iliac aneurysms
Laparoscopic observation of abdominal aortic aneurysms
Japan |
Abdominal aortic aneurysm and/or iliac artery aneurysm
Vascular surgery |
Others
NO
The aim of this study is investigate safety and efficacy of laparoscopic intraperitoneal observation in patients undergoing open surgery for abdominal aortic and iliac aneurysms. This is a pilot study to complete laparoscopic aortic surgery in the future.
Safety,Efficacy
Confirmatory
Pragmatic
Phase I,II
Efficacy: ability to observe infrarenal aorta and common iliac artery using laparoscopy
It is assessed during surgery.
Safety: to assess damage of the abdominal viscera or other adverse events at the time of discharge
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment | Maneuver |
In patients who undergo open surgery for abdominal aortic and/or iliac aneurysms, intraperitoneal space, especially infrarenal aorta, is observed using a laparoscope under general anesthesia.
After laparoscopic observation, open surgery for abdominal aortic and/or iliac aneurysms will be done.
Study period is from the day of the surgery to the day of discharge.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients falling under all the following conditions are included of this study.
1) Patients who have abdominal aortic aneurysm (the maximum diameter is more than 4.5 cm) and/or iliac aneurysms (the maximum diameter is more than 3.0 cm) and are candidates for open surgery for the disease
2) Patients whose general condition is good and who have no serious comorbidities.
3) Patients who is more than 20 years of age
4) Patients who obtained document consent by his/her free will with sufficient understanding, after receiving sufficient explanation for the participation of this study
5) Patients in a hospital
Patients who fall under any of the following conditions are excluded of this study.
1) Patients who are candidates for endovascular aneurysm repair (EVAR)
2) Ruptured aneurysms
3) Emergency operation
4) Patients who are more than 80 years of age
5) Patients who have a history of myocardial infarction, unstable angina, serious hepatic disease (AST (GOT) > 100 U and/or ALT (GTP) > 100 U), serious kidney disease (serum creatinine > 2.0 mg/dL), or serious pulmonary disease (FEV1 < 1000 ml or FEV1% < 70%)
6) Female patients who are pregnant or have the potential to become pregnant
7) Lactating female patients
8) Patients who are judged as inappropriate for research by research responsibilities (sharing) doctors
5
1st name | TOSHIFUMI |
Middle name | |
Last name | KUDO |
Tokyo Medical and Dental University
Vascular Surgery
113-8519
1-5-45, Yushima, Bunkyo-ku, Tokyo
03-5803-5255
t-kudo.srg1@tmd.ac.jp
1st name | TOSHIFUMI |
Middle name | |
Last name | KUDO |
Tokyo Medical and Dental University
Vascular Surgery
113-8519
1-5-45, Yushima, Bunkyo-ku, Tokyo
03-5803-5255
t-kudo.srg1@tmd.ac.jp
Tokyo Medical and Dental University
Tokyo Medical and Dental University
Other
IRB of Tokyo Medical and Dental University
1-5-45, Yusmiya, Bunkyo-ku, Tokyo
03-5803-5226
syomu1.adm@tmd.ac.jp
NO
2017 | Year | 05 | Month | 09 | Day |
https://www.tmd.ac.jp/srg/synnryou/vascularsrg/134_5ab8397790df6/
Published
https://www.tmd.ac.jp/srg/synnryou/vascularsrg/134_5ab8397790df6/
5
Protocol was completed in 5 patients.
2024 | Year | 04 | Month | 01 | Day |
Age: 61-68
All male
Protocol was completed in 5 patients.
none
Protocol was completed in 5 patients.
No adverse event was found in all cases.
Completed
2017 | Year | 05 | Month | 09 | Day |
2017 | Year | 06 | Month | 23 | Day |
2017 | Year | 06 | Month | 23 | Day |
2020 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 31 | Day |
2017 | Year | 05 | Month | 09 | Day |
2024 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029304